SRTA
$4.60
Strata Critical Medical, Inc.
Recent News
Strata Critical Medical, Inc. Q4 2025 Earnings Call Summary
Moby summary of Strata Critical Medical, Inc.'s Q4 2025 earnings call
Strata Critical Medical (SRTA) Earnings Call
Matthew Schneider: Thank you for standing by, and welcome to Strata Critical Medical, Inc.'s conference call and webcast for the quarter ended 12/31/2025. Before we get started, I would like to remind you of the company's forward-looking statement and safe harbor language. Statements made in this conference call that are not historical facts, including statements about future time periods, may be deemed to constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Analysts Expect Strata Critical Medical, Inc. (NASDAQ:SRTA) To Breakeven Soon
We feel now is a pretty good time to analyse Strata Critical Medical, Inc.'s ( NASDAQ:SRTA ) business as it appears the...
With 51% ownership of the shares, Strata Critical Medical, Inc. (NASDAQ:SRTA) is heavily dominated by institutional owners
Key Insights Institutions' substantial holdings in Strata Critical Medical implies that they have significant influence...
How The Keystone Acquisition Is Changing The Strata Critical Medical Investment Story
Strata Critical Medical’s fair value estimate has been nudged higher, with the price target moving from $9.25 to about $9.63 per share as analysts reassess the company’s growth prospects. The modestly upgraded outlook reflects growing confidence that the Keystone Perfusion Services acquisition can boost revenue visibility and support a more durable expansion profile. Investors can monitor how these price targets evolve and how the narrative around Strata develops in the months ahead. Analyst...